Clinical Trials

Currently Enrolling | Ongoing, Enrollment Complete | Completed Trials

Clinical Trials Currently Enrolling

Please contact the individual trial centers listed below for enrollment information. You may also click on the clinicaltrials.gov link for specific trial information.
Product Candidate Location Principal Investigator Indication Phase Contact
ENMD-2076 Indiana University Melvin and Bren Simon Cancer CenterSherif Farag, M.D.Multiple MyelomaI Dr. Sherif Farag
(317) 274-0843
ENMD-2076 Princess Margaret HospitalAmit Oza, M.D.Ovarian CancerIIStephanie Capobianco, B.Sc.,
416-946-4501 ext. 5185
ENMD-2076 Dana-Farber /Harvard Cancer CenterUrsula Matulonis, M.D.Ovarian CancerIILauren Pereira
617-632-6617
ENMD-2076 Indiana University Melvin and Bren Simon Cancer CenterDaniela Matei, MDOvarian CancerIICarol Kulesavage
317-274-0757
ENMD-2076 University of Chicago Medical CenterGini Fleming, MDOvarian CancerIIKaren Matijevich, RN, BSN, CCRC,
773-702-0725
ENMD-2076 Memorial Sloan-Kettering Cancer CenterWilliam Tew, MDOvarian CancerIIDr. Tew,
646-497-9055
ENMD-2076 University of Colorado Cancer CenterKian Behbakht, MDOvarian CancerIIJill Grothusen,
720-848-7202

Ongoing Trials, Enrollment Closed

Product Candidate Location Principal Investigator Indication Phase
MKC-1 with PemetrexedMulti-Center TrialDr. Nasser H. HannaAdvanced Cancer and Non-Small Cell Lung Cancer (NSCLC)I / II
MKC-1Multi-centerDr. Amit OzaOvarian/Endometrial CancersII
ENMD-2076University of Colorado and Dana-Farber Cancer InstituteDr. Wells Messersmith & Dr. Geoffrey ShaprioAdvanced CancersI
ENMD-2076Princess Margaret HospitalDr. Karen YeeLeukemiaI

Completed Trials

Product Candidate Location Principal Investigator Indication Phase
MKC-1 Princess Margaret HospitalDr. Karen YeeLeukemiaI
Panzem® NCD w/ Temodar® Preston Robert Tisch Brain Tumor Center at Duke University Medical CenterDr. Annick DesjardinsGlioblastoma Multiforme (GBM)II
Panzem® NCD Multi-Center TrialDr. Glenn LiuRenal Cell CarcinomaII
Panzem® NCD Multi-Center TrialDr. Glenn LiuHormone-Refractory Prostate CancerII
MKC-1 Multi-Center TrialAdvanced and Metastatic Breast CancerII
Panzem® NCD Duke University Medical CenterDr. Kimberly L. BlackwellMetastatic Breast CancerIb
Panzem® NCD Indiana University Cancer Center, Indianapolis, INDr. Christopher J. SweeneyAdvanced CancerIb (Part B)
ENMD-1198 University of Colorado Cancer Center, Aurora, CODr. Ross CamidgeAdvanced CancerI
Panzem® NCD Dana-Farber Cancer Institute, Boston, MassachusettsDr. Matthew KulkeCarcinoid CancerII
Panzem® NCD University of Wisconsin Comprehensive Cancer Center (UWCCC), Madison, WIDr. George WildingAdvanced CancerIb (Part B)
Panzem® NCD Multi-Center TrialDr. Daniela E. MateiOvarian CancerII
Panzem® NCD Brain Tumor Center at Duke University Medical Center, Durham, NCDr. David A. ReardonBrain CancerII
Panzem® NCD University of Wisconsin Comprehensive Cancer Center (UWCCC), Madison, WIDr. George WildingAdvanced CancerIb (Part A)
Panzem® NCD Indiana University Cancer Center, Indianapolis, INDr. Christopher J. SweeneyAdvanced CancerIb (Part A)
Panzem® Capsules Mayo Clinic, Rochester, MNDr. Vincent RajkumarMultiple MyelomaII
Panzem® Capsules Dana-Farber Cancer Institute, Boston, MADr. Paul RichardsonMultiple MyelomaII
Panzem® Capsules *National Cancer Institute, Bethesda, MDDr. William D. Figg, Dr. William DahutAdvanced Solid TumorsI
Panzem® Capsules **Mayo Clinic, Rochester, MNDr. Charles ErlichmanAdvanced Solid TumorsI
Panzem® Capsules University of Wisconsin, Madison, WI Dr. George WildingProstate CancerII
Panzem® Capsules Indiana University Cancer Center, Indianapolis, INDr. Chris Sweeney, Dr. George SledgeProstate CancerII
Panzem® Capsules Indiana University Cancer Center, Indianapolis, INDr. Kathy Miller , Dr. George SledgeMetastatic Breast CancerI
Panzem® Capsules w/ Taxotere® Indiana University Cancer Center, Indianapolis, INDr. Kathy Miller , Dr. George SledgeMetastatic Breast CancerI
MKC-1 Multi-centerDr. Eunice KwakPancreatic CancerII
MKC-1 University of WisconsinGlenn Liu, M.D.Advanced CancerI
* NCI-sponsored trial. EntreMed provided only the study drug for this trial.
** NCI-sponsored trial. EntreMed provided only the study drug for this trial.